trending Market Intelligence /marketintelligence/en/news-insights/trending/jW7coCNncPu0xU9U0r5ILQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Hemostemix issues debt, adds board members as part of reorganization

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Hemostemix issues debt, adds board members as part of reorganization

Hemostemix Inc. issued C$1 million worth of debt and appointed two members to its board as part of a reorganization announced in 2016.

The company added David Wood and Donald Friesen to fill two of the three vacancies created as result of Robert Bard, Victor Redekop and Robert Buckler's resignation earlier this month.

Angus Jenkins will continue to serve as the company's chairman.

Hemostemix also appointed Kyle Makofka as its chief restructuring officer. Makofka is the managing director of Drive Capital Corp. which is heading Hemostemix's restructuring efforts.

The debt was issued in the form of convertible debentures to Drive Capital which then transferred it to Wood Capital Ltd., an affiliated private equity investment firm.

The debt is convertible at a rate of 16 Canadian cents per unit. Each unit will comprise one Hemostemix share and one-half of a purchase warrant.

Each whole warrant will be exercisable into a Hemostemix share at 30 Canadian cents apiece.

Drive Capital also agreed to provide up to C$750,000 in emergency funding to help Hemostemix meet its business obligations.